Furthermore, IL-17 (in the presence of IL-23) orchestrates the conversion of ILC1 into ILC3 and inhibits the adaptive arm of an immune response in lung squamous cell carcinoma and hepatocellular carcinoma [19,20]; however, this needs to be studied in OSCC. The gene discussed is IL17A; the disease is squamous cell lung carcinoma.